Reduced Dose 4-Factor Prothrombin Complex Concentrate Prior to Heart Transplant in Patients with Ventricular Assist Devices
The journal of heart and lung transplantation/The Journal of heart and lung transplantation(2017)
摘要
Four-Factor Prothrombin Complex Concentrate (4FPCC) is used for the reversal of anticoagulation prior to orthotopic heart transplant (OHT) in patients with ventricular assist devices (VADs). Since limited evidence is available for the dosing of 4FPCC, 25-50 units/kg has been used based on package insert. We hypothesized that a lower dose of 4FPCC can be utilized in this patient population.
更多查看译文
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要